Your browser doesn't support javascript.
loading
Phenotyping and genotyping of CYP2C19 using comparative metabolism of proguanil in sickle-cell disease patients and healthy controls in Nigeria.
Adejumo, Olufunmilayo E; Kotila, Taiwo R; Falusi, Adeyinka G; Silva, Boladale O; Nwogu, Jacinta N; Fasinu, Pius S; Babalola, Chinedum P.
Afiliación
  • Adejumo OE; Department of Pharmaceutical and Medicinal Chemistry Faculty of Pharmacy Olabisi Onabanjo University Sagamu Nigeria; Department of Pharmaceutical Chemistry Faculty of Pharmacy University of Ibadan Ibadan Nigeria.
  • Kotila TR; Department of Haematology College of Medicine University of Ibadan Ibadan Nigeria.
  • Falusi AG; Genetic and Bioethics Unit Institute of Advanced Medical Research and Training (IMRAT) College of Medicine University of Ibadan Ibadan Nigeria.
  • Silva BO; Department of Pharmaceutics and Pharmaceutical Technology Faculty of Pharmacy University of Lagos Lagos Nigeria.
  • Nwogu JN; Department of Pharmaceutical Chemistry Faculty of Pharmacy University of Ibadan Ibadan Nigeria.
  • Fasinu PS; Department of Pharmaceutical and Medicinal Chemistry Faculty of Pharmacy Olabisi Onabanjo University Sagamu Nigeria; National Center for Natural Product Research School of Pharmacy University of Mississippi Oxford Mississippi United States.
  • Babalola CP; Department of Pharmaceutical Chemistry Faculty of Pharmacy University of Ibadan Ibadan Nigeria; Genetic and Bioethics Unit Institute of Advanced Medical Research and Training (IMRAT) College of Medicine University of Ibadan Ibadan Nigeria.
Pharmacol Res Perspect ; 4(5): e00252, 2016 10.
Article en En | MEDLINE | ID: mdl-27713823

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Pharmacol Res Perspect Año: 2016 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Pharmacol Res Perspect Año: 2016 Tipo del documento: Article